AMERICAN SHARED HOSPITAL SERVICES Sales Revenue, Goods, Net (Deprecated 2018-01-31)
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $19.56 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2018-03-28
- AMERICAN SHARED HOSPITAL SERVICES sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2012-12-31 was $4.13M, a 8.33% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2012-09-30 was $4.24M, a 53.69% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2011-12-31 was $4.50M, a 73.01% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2011-09-30 was $9.15M.
- AMERICAN SHARED HOSPITAL SERVICES sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $19.56M, a 4.58% increase from fiscal 2016.
- AMERICAN SHARED HOSPITAL SERVICES sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $18.70M, a 13.00% increase from fiscal 2015.
- AMERICAN SHARED HOSPITAL SERVICES sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2015 was $16.55M, a 7.34% increase from fiscal 2014.
- AMERICAN SHARED HOSPITAL SERVICES sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $15.42M, a 12.32% decline from fiscal 2013.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2017-12-31 | $19.56M 10-K · filed 2018-03-28 | ||||||
| 2016-12-31 | $18.70M 10-K · filed 2018-03-28 | ||||||
| 2015-12-31 | $16.55M 10-K · filed 2018-03-28 | ||||||
| 2014-12-31 | $15.42M 10-K · filed 2017-03-27 | ||||||
| 2013-12-31 | $17.58M 10-K · filed 2016-03-30 | ||||||
| 2012-12-31 | $4.13M derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-01 | $8.36M derived: sum of 2 quarters · filed 2015-04-01 | $17.05M 10-K · filed 2015-04-01 | ||||
| 2012-09-30 | $4.24M 10-Q · filed 2012-11-14 | $12.92M 10-Q · filed 2012-11-14 | |||||
| 2011-12-31 | $4.50M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $13.65M derived: sum of 2 quarters · filed 2014-03-31 | $22.22M 10-K · filed 2014-03-31 | $4.98M 10-K · filed 2012-03-30 | |||
| 2011-09-30 | $9.15M 10-Q · filed 2012-11-14 | $4.98M 10-Q · filed 2011-11-14 | $17.72M 10-Q · filed 2012-11-14 | $4.98M 10-Q · filed 2011-11-14 | |||
| 2010-12-31 | $16.68M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | $16.68M derived: sum of 2 quarters · filed 2013-03-29 | $16.68M 10-K · filed 2013-03-29 | $0.00 10-K · filed 2012-03-30 | |||
| 2010-09-30 | $0.00 10-Q · filed 2011-11-14 | $0.00 10-Q · filed 2011-11-14 | |||||
| 2009-12-31 | $0.00 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |